3M secures settlements in price-gouging litigation
3M has settled with two companies it had accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic.
Mylan scores multiple sclerosis patent win over Biogen
Mylan has succeeded in having a key Biogen patent covering multiple sclerosis drug Tecfidera invalidated by a US federal court.
Roche accuses competitor of infringing diabetes patent
Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.
EC backs voluntary COVID-19 vaccine licensing
The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.
MicroPort accuses rival of selling ‘knock-off’ surgical tools
MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.
UKIPO rejects Novartis’s TM opposition attempt
Switzerland-based Novartis has failed to convince the UK Intellectual Property Office that a trademark applied-for by Boston Healthcare should not be registered.
Illumina secures injunction against BGI
Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
UKIPO cancels SPC extension at owner’s request
The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.
SCOTUS refuses to hear Eli Lilly patent win
The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
BIO 2020: AI patents and secrets
Discussions around artificial intelligence (AI) and IP can sometimes be futuristic and trapped at the level of high-concept: whether machines can be inventors, for example. But at BIO Digital 2020, a panel of experts was on hand to provide a much more practical, down-to-earth guide to patenting AI inventions.
